Why the study?
Hypokalaemia is common in patients with cardiovascular disease, necessitating guidance on tight potassium regulation and management until more evidence is available.
Does tight potassium regulation improve outcomes in patients with cardiovascular disease?
Does tight potassium regulation improve outcomes in patients with cardiovascular disease?
This review emphasizes the importance of tight potassium regulation and proposes elevating potassium levels in asymptomatic patients with cardiovascular disease and lower normal potassium concentrations.
Answers are grounded in this paper and cite their sources.
Caution against adopting potassium elevation in asymptomatic CVD patients; leaves open need for RCTs to test outcome benefit.
Hypokalaemia is common in patients with cardiovascular disease. In this review, we emphasize the importance of tight potassium regulation in patients with cardiovascular disease based on findings from observational studies. To enhance the understanding, we also describe the mechanisms of potassium homeostasis maintenance, the most common causes of hypokalaemia and present strategies for monitoring and management of low potassium levels. We propose elevation of potassium in asymptomatic patients with lower normal concentrations and concurrent cardiovascular disease. These proposals are intended to assist clinicians until more evidence is available.
No takes yet. Share an insight, caveat, or question.
Krogager et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: